Hepatic artery embolization (HAE) in hepatocellular and gastroenteropancreatic neuroendocrine tumors at Instituto Oncologico Nacional, Panama

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter O. Castillo-Fernandez
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors O. Castillo-Fernandez1, H. Tapia2, M. Ruiz2, J. Pinto Llerena1, M. Lim1, Y. Pereira2, L. Montano1, M. Cukier1
  • 1Instituto Oncologico Nacional, Panama City, Panama, /
  • 2Instituto Oncologico Nacional, Panama, Panama, /


Patients with advanced hepatocellular carcinoma (HCC) and hepatic metastases from neuroendocrine tumors (NET) have few treatment options. Several reviews have suggested that HAE, with or without intraarterial chemotherapy, can be used for local control with improvement in overall survival. We conducted a study, to analyze the characteristics of patients treated with HEA in our institute.